Ada Chukwudi has lived with HIV for 10 years. In this interview with Daily Trust, she gave insights into her journey.Tell us a bit about your journey since you were diagnosed with HIV.I was diagnosed ...

In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...

Parliament passes controversial CDF constitutional amendment Malawi’s Parliament has approved Bill No. 2 of 2025, a ...

Sujata Tewari, BA, previously of the Medical Practice Evaluation Center (MPEC) at Massachusetts General Hospital, and Andrea ...

Here is a roundup of stories from The Canadian Press designed to bring you up to speed… New HIV prevention guidelines say ...

With cases rising by 3091% since 2010, Fiji is introducing same-day testing and treatment, peer education and support, and ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

An oral HIV drug helped patients with center-involved diabetic macular edema achieve improvements in visual acuity, according ...

Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read more on GILD stock here.